Guides Collective
The Weekly Guide
Resources, research, and reflections — curated each week for the guides in our community.
JUN 12, 2026
From the Platform
What's new and coming to Guides Collective.
Improving video chat functionality - exploring other video call solutions with end-to-end encryption and are compliant with our privacy standards.
Exploring a better scheduling interface that makes scheduling between guide and seeker simpler and more straight forward.
All questions or tech support issues, please email us at support@guidescollective.com
Section 01
Industry Headlines
What's happening in the psychedelic space this week.
PSYPOST · JUNE 8, 2026
Psychedelic Therapy Standardized for Clinical Depression Shows Massive Promise in Pilot Trial
Researchers combined psilocybin with cognitive behavioral therapy in a pilot study, finding that 13 of 16 participants showed significant depression reduction, with 9 achieving full remission. The structured therapeutic approach proved safe and effective over a four-month treatment period.
STARS AND STRIPES · JUNE 2, 2026
VA Launches Clinical Trial Using MDMA to Treat PTSD and Alcohol Addiction in Veterans
The Department of Veterans Affairs is launching a clinical trial enrolling 80 veterans to study MDMA-assisted therapy for severe PTSD and alcohol addiction that haven’t responded to standard treatments. The trial follows a presidential executive order to accelerate evaluation of psychedelic drugs for mental health conditions.
LUCID NEWS · FEBRUARY 4, 2026
Legislation, Industry, and the Future of Psilocybin for PTSD
The FDA recently accepted Compass Pathways’ application to study psilocybin-assisted therapy for PTSD, marking a significant expansion beyond depression and anxiety. Several states including Michigan and Massachusetts are advancing legislative measures, though scientists note the evidence base for PTSD treatment remains limited compared to ongoing clinical trials.
Section 02
From the Field
Perspectives and insights from leaders in the psychedelic space.
MARIJUANA MOMENT · JUNE 4, 2026
Connecticut Governor Signs Bill to Expand Psychedelics Pilot Program for Federal FDA Approval
Connecticut Governor Ned Lamont signed legislation expanding the state’s psychedelic-assisted therapy pilot program to any qualified adults 18 and older, removing prior restrictions limiting participation to veterans and first responders. The law also removes language requiring the program to end upon federal FDA approval, keeping Connecticut eligible for federal matching funds.
EARTH.COM · MAY 22, 2026
Psychedelic-Like Drugs May Treat Depression Without Making People Trip
Researchers at UC Davis developed D5, a novel compound created by exposing amino acids to ultraviolet light that fully activates the brain’s serotonin receptors like classical psychedelics — but produces zero hallucinogenic effects, potentially unlocking depression treatment benefits without the psychedelic experience.
Section 03
Personal Journeys
First-person accounts worth reading — perspectives that inform the work we do.
NORMALIZE PSYCHEDELICS · MAY 6, 2026
Mark “The Shark” Irwin on Using Psilocybin for Performance and Recovery
Former bare-knuckle boxing world champion Mark “The Shark” Irwin used psilocybin during his fighting career to enhance performance and confidence — and now relies on the same medicine to support his recovery from traumatic brain injuries sustained through years of professional fighting.
NORMALIZE PSYCHEDELICS · JANUARY 23, 2026
What Changed After 38 Years Sober: Linda’s First Psychedelic Experience
At 65, Linda shares how an intentional psilocybin experience after 38 years of sobriety helped her release decades of anger and anxiety — gaining newfound clarity, peace, and the freedom to step away from her business without the worry that had defined her life.